AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35983099 — intervention group
Group type: EXPERIMENTAL
Intervention: POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin)
Number of subjects: 230
Study 35983099 — intervention group
Group type: COMPARATOR
Intervention: SOX/CAPOX/FOLFOX
Number of subjects: 230
Study 32285530 — intervention group
Group type: EXPERIMENTAL
Intervention: Active commuting intervention (exact details not specified)
Number of subjects: 73
Study 32285530 — intervention group
Group type: COMPARATOR
Intervention: Control group (exact details not specified)
Number of subjects: 73
Study 34978680 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie Information
Number of subjects: 283
Study 34978680 — intervention group
Group type: COMPARATOR
Intervention: No Calorie Information
Number of subjects: 283
Study 33568018 — intervention group
Group type: EXPERIMENTAL
Intervention: habit‐forming exercise, home safety, and community mobility training
Number of subjects: 370
Study 33568018 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 370
Study 32371537 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with trastuzumab-containing regimens
Number of subjects: 130
Study 32371537 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 130
Study 34411904 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert advice about therapeutic exercise
Number of subjects: 500
Study 34411904 — intervention group
Group type: COMPARATOR
Intervention: Normal lifestyle habits (Control)
Number of subjects: 500
Study 33244571 — intervention group
Group type: EXPERIMENTAL
Intervention: SARC-F screening
Number of subjects: 122
Study 33728848 — intervention group
Group type: EXPERIMENTAL
Intervention: ipidacrine added to traditional therapy (n=50)
Number of subjects: 92
Study 33728848 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (n=42)
Number of subjects: 92
Study 34977553 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists-physicians collaborative coaching intervention delivered over two months through Facebook live sessions
Number of subjects: 0
Study 34977553 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 34977553 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists-physicians collaborative coaching intervention
Number of subjects: 0
Study 34818363 — intervention group
Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS), 2.5 g doses before sleeping on the night before surgery and 2 hours before anesthesia induction
Number of subjects: 100
Study 34818363 — intervention group
Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS)
Number of subjects: 100
Study 34818363 — intervention group
Group type: COMPARATOR
Intervention: Control (CNT), no medication preoperatively
Number of subjects: 100
Study 35500960 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine physical therapy along with Low Intensity Pulsed Ultrasound (LIPUS)
Number of subjects: 34
Study 35500960 — intervention group
Group type: COMPARATOR
Intervention: Routine physical therapy (Control Group)
Number of subjects: 34
Study 36143107 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroponic tomato puree
Number of subjects: 30
Study 36143107 — intervention group
Group type: COMPARATOR
Intervention: Conventional tomato puree
Number of subjects: 30
Study 36143107 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study 33121121 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded Plyometrics (LP)
Number of subjects: 38
Study 33121121 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloaded Plyometrics (UP)
Number of subjects: 38
Study 33121121 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 38
Study 35565110 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) prevention program
Number of subjects: 27
Study 35565110 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group (DTG, waiting list control)
Number of subjects: 27
Study 616617623 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive half-day course about information for transition to end-of-life care for physicians and nurses
Number of subjects: 8
Study 616617623 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched hospitals and municipalities)
Number of subjects: 8
Study 34427549 — intervention group
Group type: EXPERIMENTAL
Intervention: NCD prevention program
Number of subjects: 0
Study 34427549 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34010494 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine (DCS)
Number of subjects: 152
Study 34010494 — intervention group
Group type: COMPARATOR
Intervention: Control (no DCS)
Number of subjects: 152
Study 33141099 — intervention group
Group type: EXPERIMENTAL
Intervention: Group receiving all texts (comprehensive messages)
Number of subjects: 2115
Study 33141099 — intervention group
Group type: COMPARATOR
Intervention: Group receiving basic messages
Number of subjects: 2115
Study 33141099 — intervention group
Group type: COMPARATOR
Intervention: Group receiving messages regarding care seeking
Number of subjects: 2115
Study 33141099 — intervention group
Group type: COMPARATOR
Intervention: Group receiving messages regarding good home prenatal practices
Number of subjects: 2115
Study 33141099 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous cesarean section history
Number of subjects: 2115
Study 35491682 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac (IVK) administered pre-operatively
Number of subjects: 200
Study 35491682 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac (IVK) administered intra-operatively
Number of subjects: 200
Study 35491682 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac (IVK) administered post-operatively
Number of subjects: 200
Study 35491682 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IVK)
Number of subjects: 200
Study 34154341 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke Volume Variation (SVV)
Number of subjects: 35
Study 34154341 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure Variation (PPV)
Number of subjects: 35
Study 34154341 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume Expansion (VE)
Number of subjects: 35
Study 34154341 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver Operating Characteristic (ROC) curve for SVV
Number of subjects: 35
Study 34154341 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver Operating Characteristic (ROC) curve for PPV
Number of subjects: 35
Study 32564042 — intervention group
Group type: EXPERIMENTAL
Intervention: FED method
Number of subjects: 60
Study 32564042 — intervention group
Group type: COMPARATOR
Intervention: FITS method
Number of subjects: 60
Study 33185166 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX with doxycycline 200mg per day orally
Number of subjects: 160
Study 33185166 — intervention group
Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 160
Study 35709509 — intervention group
Group type: EXPERIMENTAL
Intervention: CBL-514 injection at a dose of 2.0 mg/cm2 (300 mg)
Number of subjects: 0
Study 35709509 — intervention group
Group type: EXPERIMENTAL
Intervention: CBL-514 injection at a dose of 1.6 mg/cm2 (240 mg)
Number of subjects: 0
Study 35709509 — intervention group
Group type: EXPERIMENTAL
Intervention: CBL-514 injection at a dose of 1.2 mg/cm2 (180 mg)
Number of subjects: 0
Study 33251840 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple interrupted suture pattern
Number of subjects: 9
Study 33251840 — intervention group
Group type: COMPARATOR
Intervention: Simple continuous suture pattern
Number of subjects: 9
Study 32107526 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART initiation
Number of subjects: 216
Study 32107526 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation (24 weeks)
Number of subjects: 216
Study 32107526 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART initiation (≤30 days from EDDI)
Number of subjects: 216
Study 32107526 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation (>90 days from EDDI)
Number of subjects: 216
Study 32674587 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 118
Study 32674587 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 118
Study 32674587 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise
Number of subjects: 118
Study 32674587 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 118
Study 36254811 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical health nurse intervention
Number of subjects: 77
Study 36254811 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 77
Study 34506326 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial laparotomy
Number of subjects: 310
Study 34506326 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal drainage
Number of subjects: 310
Study 34506326 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial laparotomy (with preoperative diagnosis of NEC)
Number of subjects: 310
Study 34506326 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal drainage (with preoperative diagnosis of NEC)
Number of subjects: 310
Study 34506326 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial laparotomy (with preoperative diagnosis of IP)
Number of subjects: 310
Study 34506326 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal drainage (with preoperative diagnosis of IP)
Number of subjects: 310
Study 35189351 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful conditioning stimulus (12 °C water bath)
Number of subjects: 54
Study 35189351 — intervention group
Group type: COMPARATOR
Intervention: Nonpainful conditioning stimulus (22 °C water bath)
Number of subjects: 54
Study 34454810 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring (e-Vita HF platform) instead of face-to-face consultations
Number of subjects: 223
Study 34454810 — intervention group
Group type: COMPARATOR
Intervention: Usual HF outpatient care
Number of subjects: 223
Study 34454810 — intervention group
Group type: COMPARATOR
Intervention: Usual care combined with the use of the website heartfailurematters.org
Number of subjects: 223
Study 33492878 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 60
Study 33492878 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 60
Study 33492878 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 33470152 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulation restarted after 1 week
Number of subjects: 0
Study 33470152 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulation restarted after 2 weeks
Number of subjects: 0
Study 33470152 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulation restarted after 4 weeks
Number of subjects: 0
Study 32430108 — intervention group
Group type: EXPERIMENTAL
Intervention: POCUS
Number of subjects: 60
Study 32430108 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 34651171 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) hydration
Number of subjects: 51
Study 34651171 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) hydration
Number of subjects: 51
Study 34497023 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Composite Restorations (DCR)
Number of subjects: 41
Study 34497023 — intervention group
Group type: COMPARATOR
Intervention: Indirect Composite Restorations (ICR)
Number of subjects: 41
Study 35264347 — intervention group
Group type: EXPERIMENTAL
Intervention: VATS procedure with drainage
Number of subjects: 184
Study 35264347 — intervention group
Group type: COMPARATOR
Intervention: TUS-guided pigtail catheter placement and intrapleural therapy with Actilyse and DNase
Number of subjects: 184
Study 34081259 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-enlarged axillary lymph nodes visualized on breast MRI
Number of subjects: 431
Study 34081259 — intervention group
Group type: EXPERIMENTAL
Intervention: Size of fat-enlarged nodes in the contralateral axilla identified on breast MRI
Number of subjects: 431
Study 36130946 — intervention group
Group type: EXPERIMENTAL
Intervention: Neflamapimod 40 mg
Number of subjects: 91
Study 36130946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 33172597 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 2084
Study 32057924 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (5Hz) rTMS stimulation on pre-SMA region
Number of subjects: 16
Study 32057924 — intervention group
Group type: COMPARATOR
Intervention: High-frequency (5Hz) rTMS stimulation on M1 region
Number of subjects: 16
Study 35880801 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 100
Study 35880801 — intervention group
Group type: COMPARATOR
Intervention: Healthy Lifestyle (HL)
Number of subjects: 100
Study 34106607 — intervention group
Group type: EXPERIMENTAL
Intervention: Genoss DES
Number of subjects: 77
Study 34106607 — intervention group
Group type: COMPARATOR
Intervention: Promus Element
Number of subjects: 77
Study 32726873 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based 'three good things' (3GT)
Number of subjects: 73
Study 32726873 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study 35063281 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 80mg/m2 weekly up to 24 weeks (control)
Number of subjects: 123
Study 35063281 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 300mg tablets twice daily + Cediranib 20mg daily (continuous schedule)
Number of subjects: 123
Study 35063281 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 300mg tablets twice daily + Cediranib 20mg 5 days/week (intermittent schedule)
Number of subjects: 123
Study 32844807 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline
Number of subjects: 40
Study 32844807 — intervention group
Group type: COMPARATOR
Intervention: 20% mannitol
Number of subjects: 40
Study 35151415 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and low-dose dexamethasone
Number of subjects: 307
Study 35151415 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and low-dose dexamethasone (Control)
Number of subjects: 307
Study 32956630 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral arterial disease present
Number of subjects: 4060
Study 32956630 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral arterial disease present (non-anticoagulated atrial fibrillation)
Number of subjects: 4060
Study 32956630 — intervention group
Group type: COMPARATOR
Intervention: Peripheral arterial disease absent
Number of subjects: 4060
Study 32312065 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF)
Number of subjects: 41
Study 32312065 — intervention group
Group type: COMPARATOR
Intervention: Simple tube feeding (STF)
Number of subjects: 41
Study 33842984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracongruent (UC) insert design
Number of subjects: 127
Study 33842984 — intervention group
Group type: COMPARATOR
Intervention: Posterior stabilized (PS) design
Number of subjects: 127
Study 33307657 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval aerobic work (120 days, 3 times a week on a bicycle ergometer)
Number of subjects: 55
Study 33307657 — intervention group
Group type: COMPARATOR
Intervention: Traditional strength protocol (120 days, 3 times a week)
Number of subjects: 55
Study 34506761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (600 mg/m2) plus uromitexan (200 mg/m2) at days 0, 15, 30, and 60
Number of subjects: 120
Study 34506761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 34506761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 120
Study 32094016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac catheterisation laboratory without a Medical emergency team
Number of subjects: 75
Study 32094016 — intervention group
Group type: EXPERIMENTAL
Intervention: Post percutaneous coronary intervention
Number of subjects: 75
Study 35395289 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable cardioverter defibrillator (WCD)
Number of subjects: 0
Study 35395289 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0
Study 33528369 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat group
Number of subjects: 200
Study 33528369 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 33528369 — intervention group
Group type: COMPARATOR
Intervention: Comparison between WeChat and Control groups
Number of subjects: 200
Study 33528369 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction survey on WeChat management
Number of subjects: 200
Study 35452861 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 3g administered intra-articular after cementation and prior to capsular closure
Number of subjects: 150
Study 35452861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 35508352 — intervention group
Group type: EXPERIMENTAL
Intervention: NAT-guided clinical consultation plus usual care
Number of subjects: 1080
Study 35508352 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 1080
Study 34895291 — intervention group
Group type: EXPERIMENTAL
Intervention: TGTG group (Treated with Genetic Test Guide)
Number of subjects: 300
Study 34895291 — intervention group
Group type: COMPARATOR
Intervention: TAU group (Treated as Usual)
Number of subjects: 300
Study 35075022 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot caudal morphine
Number of subjects: 60
Study 35075022 — intervention group
Group type: COMPARATOR
Intervention: Intravenous narcotic-based anesthesia
Number of subjects: 60
Study 34454540 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azacitidine 300 mg once-daily for 14 days in repeated 28-day cycles
Number of subjects: 469
Study 34454540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study 34454540 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azacitidine
Number of subjects: 469
Study 32649708 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk 3.6% fat + RE
Number of subjects: 30
Study 32649708 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk 0.3% fat + RE
Number of subjects: 30
Study 32649708 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric carbohydrate drink + RE
Number of subjects: 30
Study 34957954 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 8 U/kg
Number of subjects: 381
Study 34957954 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 4 U/kg
Number of subjects: 381
Study 34957954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study 32080847 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversity training focusing on ingroup privilege awareness
Number of subjects: 112
Study 32080847 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study 35556335 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive aerobic cycling exercise for 20-45 min up to 80% of heart rate reserve, 3 days/week for 12 weeks
Number of subjects: 10
Study 35556335 — intervention group
Group type: COMPARATOR
Intervention: Non-aerobic, stretching exercise, 3 days/week for 12 weeks
Number of subjects: 10
Study 32333883 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (dietary counselling)
Number of subjects: 1116
Study 34366432 — intervention group
Group type: EXPERIMENTAL
Intervention: WISER intervention
Number of subjects: 481
Study 34366432 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 481
Study 32371073 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater reliability assessment using unweighted kappa
Number of subjects: 100
Study 32371073 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater reliability assessment using weighted kappa
Number of subjects: 100
Study 32371073 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater reliability for noted present symptoms
Number of subjects: 100
Study 32371073 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater reliability for noted absent symptoms
Number of subjects: 100
Study 36326299 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour cherry concentrate (75 ml twice daily for 2 weeks)
Number of subjects: 70
Study 36326299 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 70
Study 33465768 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 784
Study 33465768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 784
Study 33465768 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (in patients with cortical anterior circulation infarction)
Number of subjects: 784
Study 33465768 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in patients with cortical anterior circulation infarction)
Number of subjects: 784
Study 33465768 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam vs. Placebo (in patients with cortical anterior circulation infarction)
Number of subjects: 784
Study 32681461 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (1–600 mg single dose)
Number of subjects: 0
Study 32681461 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (10–300 mg bid and 600 mg qd for 14 days)
Number of subjects: 0
Study 32681461 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (single and multiple doses)
Number of subjects: 0
Study 32681461 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (multiple doses)
Number of subjects: 0
Study 32681461 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (single dose with food)
Number of subjects: 0
Study 35246425 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined lifestyle intervention (GLI) for 24 months in addition to usual care
Number of subjects: 234
Study 35246425 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 234
Study 34583214 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-curcumin
Number of subjects: 80